See highlights from GHTC's 2023 Innovating for Impact Awards

Search the GHTC website

GHTC submits FY23 testimony to House appropriators

Read time: 20 minutes
PATH/Christopher Nelson
June 3, 2022

GHTC submitted written testimony to the House appropriations subcommittees with jurisdiction over the US Agency for International Development and Department of State and the Department of Health and Human Services and its subagencies, urging these subcommittees to sustain and protect global health R&D funding in the fiscal year 2023 (FY23) budget.

Testimony to House Appropriations Subcommittee on State, Foreign Operations, and Related Programs
Testimony to House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies
Tags: Advocacy action
Other news articles you may like:
PATH/Will Boase
June 16, 2022

GHTC submits FY23 testimony to Senate SFOPs appropriators

Read time: 8 minutes
PATH/Will Boase
May 28, 2022

GHTC joins statement to World Health Assembly on immunization, infection control, and meningitis

Read time:
The following statement—from Global Health Council, supported by the Global Health Technologies Coalition—was delivered at the 75th World Health Assembly on agenda items 14.5: Immunization Agenda 2030; 14.6 Infection prevention and control; and 14.7 Global road map on defeating meningitis by 2030.The COVID-19 pandemic has overwhelmed immunization infrastructure and workforce, impacted the global supply chain, increased the incidence of antimicrobial resistance (AMR), and derailed gains made in immunization campaigns around the world.We therefore call on WHO and member states to:Focus on the full spectrum of innovations that support immunization programs. Support implementation research and the development of formal feedback loops to monitor follow-up of recommendations made by groups such as the WHO Strategic Advisory Group of Experts on Immunization. Strengthen manufacturing capacities in low-and-middle-income countries.Invest in scaling up access to WASH in healthcare facilities as an essential part of infection prevention and control and combating AMR.